I stopped Latuda (lurasidone) 11 days ago; are headaches a common withdrawal symptom?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Headaches After Stopping Latuda: Understanding Withdrawal Symptoms

Headaches are not specifically documented as a common withdrawal symptom from Latuda (lurasidone) discontinuation in the FDA drug label or clinical literature, though withdrawal symptoms can occur when antipsychotics are stopped abruptly. 1

What the Evidence Shows

The FDA label for Latuda does not list headaches as a typical discontinuation or withdrawal symptom 1. The most commonly reported adverse reactions during Latuda treatment include somnolence, akathisia, extrapyramidal symptoms, and nausea, but specific withdrawal symptoms upon discontinuation are not extensively characterized in the prescribing information.

Understanding Antipsychotic Withdrawal

While Latuda-specific withdrawal data is limited, the broader medical literature on medication discontinuation provides relevant context:

  • General withdrawal patterns: When psychotropic medications are stopped, particularly after prolonged use, patients may experience various discontinuation symptoms 2
  • Timing consideration: At 11 days post-discontinuation, you are past the typical acute withdrawal window for most antipsychotics, which usually peaks within the first few days to one week

Alternative Explanations to Consider

Your headaches may be:

  1. Unrelated to Latuda discontinuation - Given the timing (11 days out) and lack of documented association
  2. Related to underlying condition changes - Bipolar disorder or schizophrenia symptoms may be re-emerging
  3. Due to other factors - Stress, sleep changes, or other medications

Clinical Pitfalls to Avoid

  • Don't assume all symptoms after stopping medication are withdrawal - The temporal relationship doesn't always equal causation, especially beyond the first week
  • Monitor for psychiatric symptom recurrence - The more concerning issue with stopping Latuda is potential return of the underlying psychiatric condition rather than withdrawal symptoms per se
  • Consider medication-overuse headache - If you were taking other headache medications or analgesics, this could be a more likely explanation 3

What You Should Do

Contact your prescribing physician immediately to discuss:

  • Whether the headaches represent a concerning pattern
  • Whether your underlying psychiatric condition is adequately managed without Latuda
  • Whether you need alternative treatment or gradual reintroduction of medication

The abrupt discontinuation of antipsychotics without medical supervision can lead to relapse of the underlying psychiatric condition, which is a more significant concern than withdrawal symptoms themselves.

Related Questions

What symptoms can be expected on day 12 after stopping Latuda (lurasidone)?
What can I expect after stopping Latuda (lurasidone) after 13 days of use?
After stopping Latuda (lurasidone) abruptly after 22 days, when can I expect my neurological function to return to normal?
In a 16‑year‑old patient on lurasidone (60 mg daily) for three weeks who reports worsening depression, irritability, and episodes of zoning out, what is the appropriate next step in management?
I have been off Latuda (lurasidone) for 21 days; when can I expect to feel better?
What is the proper way to administer psyllium, including dosage and fluid requirements, to a patient?
In a 5-year-old boy with autism spectrum disorder, a texture‑restricted diet, and constipation but no celiac disease, should a gluten‑free diet be recommended to improve his constipation or anger outbursts, given the risk of nutritional deficiencies?
How should surgical prophylaxis be administered for abdominal surgery using ceftriaxone and metronidazole?
What oral step‑down antibiotic should be prescribed for a patient with bronchiectasis being discharged after intravenous ceftazidime therapy?
In an 8‑year‑old with progressive daily headaches, new blurry vision and bitemporal peripheral visual field loss, polyuria, nocturnal enuresis, constipation, fatigue, a decline in height percentile, modest weight gain, and diffusely dry skin, which diagnostic test is most likely to provide a definitive diagnosis: dilated funduscopic examination, lumbar puncture with opening pressure measurement, or contrast‑enhanced magnetic resonance imaging (MRI) of the brain?
How should urinalysis findings be interpreted?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.